Skip to main content
. 2020 Oct 15;43(12):3094–3101. doi: 10.2337/dc20-0886

Table 3.

HRs for major CVD, all-cause mortality, and CV mortality in HIC, MIC, and LIC

n HIC MIC LIC
Major CVD, n (%) 498 (3.1) 3,743 (4.1) 1,719 (5.4)
 Model 1 124,067 2.13 (1.72–2.64) 1.92 (1.77–2.09) 1.94 (1.69–2.22)
 Model 2 106,924 1.84 (1.46–2.33) 1.74 (1.59–1.91) 1.86 (1.57–2.21)
 Model 3 106,924 1.59 (1.17–2.15) 1.70 (1.52–1.89) 1.82 (1.50–2.20)
All-cause mortality, n (%) 395 (2.4) 3,818 (4.2) 3,378 (10.5)
 Model 1 124,067 1.36 (1.05–1.78) 1.44 (1.32–1.58) 1.33 (1.18–1.49)
 Model 2 106,924 1.20 (0.90–1.61) 1.37 (1.24–1.52) 1.51 (1.31–1.75)
 Model 3 106,924 0.99 (0.68–1.45) 1.18 (1.03–1.34) 1.40 (1.18–1.66)
CV mortality, n (%) 59 (0.4) 1,068 (1.2) 999 (3.1)
 Model 1 124,067 1.84 (1.01–3.37) 1.64 (1.39–1.94) 1.89 (1.58–2.27)
 Model 2 106,924 1.44 (0.76–2.75) 1.48 (1.24–1.78) 1.89 (1.48–2.40)
 Model 3 106,924 1.63 (0.76–3.48) 1.14 (0.90–1.45) 1.78 (1.36–2.34)

Data are HR (95% CI) unless otherwise noted. Reference group: individuals without diabetes. Model 1: adjusted for age, sex, ethnicity, and center (as random effect). Model 2: model 1 + behavioral factors (physical activity level, smoking), BMI, and hypertension. Model 3: model 2 + treatments (BP-, cholesterol-, and glucose-lowering agents and aspirin).